Reuters logo
UPDATE 1-NORDIC STOCKS - Factors to watch on July 4
July 4, 2013 / 6:16 AM / 4 years ago

UPDATE 1-NORDIC STOCKS - Factors to watch on July 4

HELSINKI, July 4 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Thursday:

GENMAB

The Danish biotech firm said its collaborator, drug giant GlaxoSmithKline Plc‘s, would start a new phase 3 study of ofatumumab to treat pemphigus vulgaris, a rare autoimmune disorder of the skin. Ofatumumab, Genmab’s only drug, is sold under the name Arzerra for the treatment of blood cancer.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below